![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Malm Johan
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.14, Iss.8, 2004-08, pp. : 1169-1183
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic patents for cytomegalovirus
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic patents for the treatment of pre-eclampsia
By Page Nigel M
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective activators of thyroid hormone receptors
By Webb Paul
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. :